Vascular Endothelial Growth Factor (VEGF) (V-3) antibody

Antigen: Vascular Endothelial Growth Factor (VEGF)

Synonyms: vegf-A, VEGF, DmVEGF-1, EP1624, PVF, PVF1, PVFs, VEGF2-B, Vegf17E, Vegf17e-a, Vegf17e-b, l(1)G0146, vegf1, DmelCG7103, CG7103, DmVEGF-2, PV2, PVF2, VEGF-2, VEGF27Cb, DmelCG13780, CG13780, CG13781, CG13782, CG13783, CG31629, CG4492, DmVEGF-3, PVF3, VEGF27Ca, DmelCG34378, CG34378, vegf, LOC100033839

Epitope: V-3

Clonality: Polyclonal

Host: Rabbit

Application: Immunohistochemistry (IHC), Western Blotting (WB)

Catalog no.: ABIN180159

Additional Information

Alternative name: VEGF (V-3)

Immunogen: Synthetic peptide for Human VEGF conjugating bovine thyroglobulin Purification: Affinity Purified with synthetic peptide

Isotype: IgG  (Matching secondary antibodies)

Description: Vascular Endothelial Cell Growth Factor (VEGF) is a homodimeric protein initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and secreted by a variety of vascularized tissues. It was subsequently found to be identical to a vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based upon its ability to increase the permeability of capillary blood vessels. The reported activities of VEGF include stimulation of endothelial cell growth, angiogenesis and capillary permeability. Human VEGF is a 38.2kDa homodimeric protein consisting of two 165 amino acid polypeptide chains. VEGF is expressed in many human tumor cells, including human adenocarcinoma, human pancreatic carcinoma, human hepatocellular carcinoma, renal cell carcinoma, fibrosarcoma, HL60 promyelocytic leukemia, GS-9L glioma and U937 lymphoma cells. In normal tissues, VEGF expression has been observed in activated macrophages, keratinocytes, hepatocytes, smooth muscle cells Leydig cells, embryonic fibroblasts and bronchial and choroids plexus epithelium, renal glomerular visceral epithelium and mesangial cells.

Specificity: Human, Rat, Mouse. This antibody does not react with Human VEGF121 Chemotactic: Inhibit migration of neutrophil (up to 6 nM) at 10 ug/ml Activity

Synonyms: vegf-A, VEGF, DmVEGF-1, EP1624, PVF, PVF1, PVFs, VEGF2-B, Vegf17E, Vegf17e-a, Vegf17e-b, l(1)G0146, vegf1, DmelCG7103, CG7103, DmVEGF-2, PV2, PVF2, VEGF-2, VEGF27Cb, DmelCG13780, CG13780, CG13781, CG13782, CG13783, CG31629, CG4492, DmVEGF-3, PVF3, VEGF27Ca, DmelCG34378, CG34378, vegf, LOC100033839

Application Details

Application Notes: This antibody can be stained both in frozen sections and in formalin fixed paraffin embedded tissues by several Immunohistochemical techniques such as Avidin Biotin Complex (ABC) Method. The optimal dilution is 2-5 ug/ml, however, the dilution rate should be optimized by each laboratories.:This antibody can be used for western blotting in concentration of 2-5 ug/ml.

Purification: Antigen peptide

Buffer: Lyophilized product from 1% BSA in PBS containing 0.05%NaN3 . Reconstitution: 1 ml distilled water will be added to the product

Storage: Lyophilized product, 5 years at 2 ­ 8 : Solution, 2 years at ­20

Research Area: Cancer

Restrictions: For Research Use only

Images

Human colon cancer

anti-Vascular Endothelial Growth Factor (VEGF) (V-3) antibody (Image 2)